N07.A Hereditary nephropathy, not elsewhere classified with C3 glomerulonephritis

Name of the Condition

• Hereditary Nephropathy, Not Elsewhere Classified with C3 Glomerulonephritis
• ICD-10 Code: N07.A

Summary

Hereditary nephropathy, not elsewhere classified with C3 glomerulonephritis, is a genetic kidney disorder characterized by inherited abnormalities in the glomeruli, the kidney's filtering units, specifically involving C3 glomerulonephritis. This condition results from genetic mutations that disrupt the complement system, leading to abnormal immune complex deposition in the kidneys. It is distinct from other hereditary nephropathies due to its association with C3 glomerulonephritis, a pattern of kidney injury linked to complement dysregulation. Management focuses on slowing disease progression and addressing complications related to impaired kidney function.

Causes

This condition is caused by genetic mutations that affect the complement system, a key component of the immune response. These mutations disrupt normal complement regulation, leading to uncontrolled activation and deposition of C3 in the glomeruli. The specific genetic defects may vary, but they typically involve genes related to complement factor H, factor I, or membrane cofactor protein. Inheritance patterns can be autosomal dominant or recessive, and the condition is diagnosed when hereditary kidney disease is associated with C3 glomerulonephritis that does not fit into more specific subcategories.

Risk Factors

• Family history: A genetic predisposition to complement-related kidney disease increases risk.
• Inherited complement mutations: Specific gene variants affecting complement regulation.
• Consanguinity: Higher likelihood of recessive genetic disorders in closely related families.

Symptoms

• Hematuria (blood in urine), which may be microscopic or visible.
• Proteinuria (excess protein in urine), potentially causing foamy urine.
• Reduced kidney function, which may be asymptomatic in early stages.
• Edema (swelling) due to fluid retention.
• Hypertension (high blood pressure) as kidney function declines.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and kidney biopsy. Urinalysis may reveal hematuria or proteinuria, while blood tests assess kidney function (e.g., creatinine, estimated glomerular filtration rate) and complement levels (e.g., C3, C4). A kidney biopsy is critical to confirm C3 glomerulonephritis, showing characteristic immune complex deposition and complement activation. Genetic testing may be performed to identify underlying mutations, though the specific genetic cause may remain unidentified in some cases.

Treatment Options

Treatment aims to slow disease progression and manage complications. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) are commonly used to reduce proteinuria and control blood pressure. Immunosuppressive therapies, such as corticosteroids or complement inhibitors, may be considered in select cases to modulate the immune response. Dialysis or kidney transplantation may be necessary in advanced stages of kidney failure.

Prognosis and Follow-Up

Prognosis varies depending on the severity of kidney damage and response to treatment. Early diagnosis and intervention can slow progression, but some patients may develop end-stage renal disease (ESRD) over time. Regular monitoring of kidney function, blood pressure, and proteinuria is essential. Follow-up care includes ongoing assessment of complement levels and potential adjustments to treatment based on disease activity.

Complications

• End-stage renal disease (ESRD): Progressive kidney failure requiring dialysis or transplantation.
• Hypertension: Chronic high blood pressure due to impaired kidney function.
• Proteinuria: Persistent excess protein in urine, increasing cardiovascular risk.
• Edema: Fluid retention leading to swelling in the legs, ankles, or abdomen.
• Infections: Increased susceptibility due to immunosuppressive therapies.

Lifestyle & Prevention

• Blood pressure management: Maintain healthy blood pressure through diet, exercise, and medication.
• Dietary modifications: Limit sodium and protein intake to reduce kidney strain.
• Avoid nephrotoxins: Refrain from medications or substances that may harm the kidneys.
• Regular monitoring: Follow up with a nephrologist to track kidney function and adjust treatment as needed.

When to Seek Professional Help

Seek medical attention if you experience persistent hematuria, foamy urine, unexplained swelling, or changes in urination patterns. Prompt evaluation is critical if kidney function declines rapidly or if symptoms worsen despite treatment. Early intervention can help manage complications and improve outcomes.

Tips for Medical Coders

When coding for hereditary nephropathy with C3 glomerulonephritis, ensure the documentation supports the diagnosis and specifies the association with C3 glomerulonephritis. Verify that the condition is not classified under a more specific code elsewhere in the ICD-10-CM system. Document any genetic testing results or family history that confirms the hereditary nature of the disease, as this may be relevant for coding accuracy. Use N07.A only when the condition is explicitly described as hereditary nephropathy with C3 glomerulonephritis and does not align with other specified subcategories.